# Peking and Rotterdam on Mission to Reduce Coronary Artery Disease

> **NCT01653119** · NA · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Diabetes Mellitus

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01653119
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2015-06
- **Final completion:** 2015-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2012-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653119, "Peking and Rotterdam on Mission to Reduce Coronary Artery Disease". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01653119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*